Target intelligence / Profile preview

Carbohydrate-digesting enzyme

Molecular classification
Enzyme, Hydrolase, Digestive enzyme
01

Overview

Carbohydrate-digesting enzymes are a group of hydrolases responsible for breaking down complex carbohydrates into absorbable monosaccharides. The process begins in the mouth with **salivary amylase**, which starts hydrolyzing starches into smaller oligosaccharides[5][6][7]. In the small intestine, **pancreatic amylase** continues this process by further degrading starches to maltose and dextrins[1][2][6]. Final digestion occurs at the brush border membrane of enterocytes via specific disaccharidases—**maltase**, **sucrase**, **lactase**, and **isomaltase**—which convert disaccharides like maltose, sucrose, lactose, and limit dextrins into their constituent monosaccharides such as glucose, fructose, and galactose[2][5][6]. These enzymes are essential for nutrient absorption; deficiencies or inhibition can lead to malabsorption syndromes or be therapeutically targeted in conditions like diabetes mellitus using drugs such as acarbose or miglitol that inhibit these enzymes to slow carbohydrate absorption[7]. However "Carbohydrate-digesting enzyme" is not a single molecule but rather refers collectively to several distinct digestive enzymes. For structured data purposes it is preferable to specify individual targets such as "Salivary amylase," "Pancreatic amylase," or specific brush border disaccharidases ("Lactase," "Sucrase," etc.), since each has unique properties and clinical relevance. Therefore this entry is considered too broad/unspecific for canonical target mapping[1][2][5].

Other names
AmylaseDisaccharidaseSalivary amylasePancreatic amylaseMaltaseSucraseLactaseIsomaltase
02

Mechanism of action

Inhibition of carbohydrate-digesting enzymes to delay glucose absorption and reduce postprandial blood sugar spikes (as with acarbose and miglitol)

03

Biological functions

Digestion of carbohydratesHydrolysis of polysaccharides and disaccharides into monosaccharides
04

Disease associations

Malabsorption syndromes (e.g., lactose intolerance)Pancreatic insufficiency (e.g., chronic pancreatitis, cystic fibrosis)Other gastrointestinal disorders
05

Safety considerations

Gastrointestinal side effects from enzyme inhibitors (flatulence, diarrhea)Risk of hypoglycemia when used with other antidiabetic agents
06

Interacting drugs

Acarbose

1 more in the full profile.

07

Biomarkers

Fecal elastase (for pancreatic function; indirect marker)Breath hydrogen test (for lactase deficiency/lactose intolerance)

Beyond the preview

Go deeper on Carbohydrate-digesting enzyme.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Carbohydrate-digesting enzyme.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call